← Back to headlines
Novo Nordisk Executive Discusses Future Investments and Drug Development
Mike Doustdar, a top executive at Novo Nordisk, has announced plans to invest billions in new drug development, aiming to secure the pharmaceutical giant's future. He acknowledged that the company might face failures but is determined to leave Novo Nordisk in a stronger position.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
